Home › Funds › EdgePoint Investment Group Inc. › DGX
EdgePoint Investment Group Inc. position in DGX
QUEST DIAGNOSTICS INC · Health Care
EdgePoint Investment Group Inc. reported holding 2,247,568 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$476.4M, representing 3.60% of its reported portfolio and ranking #14 among its reported holdings. EdgePoint Investment Group Inc. has disclosed DGX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EdgePoint Investment Group Inc.'s DGX position evolved
EdgePoint Investment Group Inc. first disclosed a stake in DGX in Q2 2025 at 1,271 shares (US$228K). The position peaked in Q2 2026 at 2,247,568 shares, worth US$476.4M. Across 5 filings, EdgePoint Investment Group Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,247,568 shares valued at US$476.4M. Notable position changes include a 66757% increase in Q3 2025 (shares fell 9% over the following quarter), a 95% increase in Q4 2025 (shares rose 13% over the following quarter), a 35% increase in Q1 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.27K | $228.31K | New |
| Q3 2025 | 849.75K | $161.95M | Add |
| Q4 2025 | 1.66M | $288.25M | Add |
| Q1 2026 | 2.24M | $439.75M | Add |
| Q2 2026 | 2.25M | $476.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 30 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M), DAVIS SELECTED ADVISERS (US$329.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on EdgePoint Investment Group Inc.
FAQ
How long has EdgePoint Investment Group Inc. held DGX?
EdgePoint Investment Group Inc. has disclosed DGX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is EdgePoint Investment Group Inc.'s current position in DGX?
As of Q2 2026, EdgePoint Investment Group Inc. holds 2.25M shares of DGX (QUEST DIAGNOSTICS INC), valued at $476.37M, representing 3.60% of its reported portfolio and ranking #14.
Has EdgePoint Investment Group Inc. been buying or selling DGX?
In the latest 13F filing (Q2 2026), EdgePoint Investment Group Inc. held unchanged its position in DGX. The position peaked in Q2 2026 at 2.25M shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, Grantham, Mayo, Van Otterloo & Co. LLC, DAVIS SELECTED ADVISERS, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.